Condition: Cerebral Small Vessel Diseases · Cadasil · HTRA1-Related Autosomal Dominant Cerebral Angiopathy · Sponsor: National Taiwan University Hospital
The TAG-SVD enrolled patients with clinical and neuroimaging features of cerebral small vessel disease (CSVD). All enrolled patients will receive next-generation sequence (NGS) with probes designed to target five candidate CSVD genes, and patients will be divided into genetic or non-genetic groups accordingly. Their clinical features and outcome will be followed for at least 2 years.
This description comes directly from the study's public registry record.
Sung-Chun Tang, MD, PhD · 886972651113 · sctang@ntuh.gov.tw
Chih-Hao Chen, MD, PhD · 886987392027 · antonychen@ntu.edu.tw
Always discuss trial participation with your own doctor first.
| Department of Neurology, National Taiwan University Hospital | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05473637